NL0011606264 - MRUS - A2AKFX (XNMS)
MERUS N.V. Aktie
50,81 USD
Aktuelle Kurse von MERUS N.V.
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
MRUS
|
USD
|
19.09.2024 22:00
|
50,81 USD
| 49,42 USD | 2,81 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 1,34 % | -2,90 % | -6,32 % | 12,89 % | 103,40 % | 164,22 % |
Firmenprofil zu MERUS N.V. Aktie
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1. The company is also developing MCLA-158, which is in a phase I clinical trial for the treatment of solid tumors; MCLA-145, which is in phase 1 clinical trials for the treatment of solid tumors; MCLA-129, which is in phase 1/2 clinical trials for the treatment of patients with advanced non-small cell lung cancer and other solid tumors; and ONO-4685 that is Phase 1 clinical trial to treat relapsed/refractory T cell lymphoma. In addition, it has collaboration agreement with Betta Pharmaceuticals Co. Ltd for the research and development of stage bispecific antibody candidates include MCLA-129; and collaboration with Incyte Corporation for the development of MCLA-145. The company was incorporated in 2003 and is headquartered in Utrecht, the Netherlands.
Unternehmensdaten zur MERUS N.V. Aktie
Name MERUS N.V.
Firma Merus N.V.
Symbol MRUS
Website https://www.merus.nl
Heimatbörse
NASDAQ/NMS (GLOBAL MARKET)
WKN A2AKFX
ISIN NL0011606264
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Sven Ante Lundberg M.D.
Marktkapitalisierung 3 Mrd.
Land Niederlande
Währung USD
Mitarbeiter 0,2 T
Adresse Yalelaan 62, 3584 CM Utrecht
IPO Datum 2016-05-19
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | 2GH.F |
NASDAQ | MRUS |
Weitere Aktien
Investoren die MERUS N.V. halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024